Acute and chronic kidney function decline in patients receiving BRAF/MEK inhibitors for melanoma

被引:1
|
作者
Mistry, Kavita [1 ,2 ]
Zhao, Sophia [3 ]
Strohbehn, Ian [4 ]
Wang, Qiyu [4 ]
Hanna, Paul [4 ,5 ]
Strohbehn, Samuel [4 ]
Katz-Agranov, Nurit [4 ]
Sullivan, Ryan J. [6 ]
Sise, Meghan E. [4 ]
机构
[1] Beth Israel Deaconess Med Ctr, Dept Med, Div Nephrol, Boston, MA USA
[2] Brigham & Womens Hosp, Dept Med, Boston, MA USA
[3] Analyt Now LLC, Brookline, MA USA
[4] Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA 02114 USA
[5] Med Coll Wisconsin, Dept Med, Div Nephrol, Milwaukee, WI USA
[6] Massachusetts Gen Hosp, Dept Med, Div Hematol & Oncol, Boston, MA USA
关键词
METASTATIC MELANOMA; DOUBLE-BLIND; OPEN-LABEL; VEMURAFENIB; PHASE-3; MULTICENTER; DABRAFENIB; TRAMETINIB; PLACEBO; ENCORAFENIB;
D O I
10.1093/ndt/gfae049
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
10.1093/ndt/gfae049 Video Watch the video of this contribution at https://academic.oup.com/ndt/pages/author_videos gfae049Media1 6348384678112
引用
收藏
页码:1040 / 1043
页数:4
相关论文
共 50 条
  • [41] Cardiovascular monitoring in metastatic melanoma patients undergoing combination therapy with BRAF and MEK inhibitors
    Guglielmi, Giulia
    Sarocchi, Matteo
    Tini, Giacomo
    Schiavone, Arianna
    Toma, Matteo
    Spagnolo, Francesco
    Tanda, Enrica Teresa
    Boutros, Andrea
    Spallarossa, Paolo
    Porto, Italo
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N20 - N21
  • [42] Impact of BRAF and MEK Inhibitors on Gingival Hyperplasia in Melanoma Patients-A Case Report
    Veljovic, Tanja
    Djuric, Milanko
    Gusic, Ivana
    Vuckovic, Nada
    Ramic, Bojana
    Mirnic, Jelena
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (01)
  • [43] The concomitant use of proton pump inhibitors and BRAF/MEK inhibitors in metastatic melanoma
    Poizeau, Florence
    Balusson, Frederic
    Lemaitre, Florian
    Tron, Camille
    Pracht, Marc
    Russo, David
    Dinulescu, Monica
    Lesimple, Thierry
    Oger, Emmanuel
    Dupuy, Alain
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188 (04) : 482 - 490
  • [44] Response to BRAF and MEK Inhibitors in BRAF Thr599dup-Mutated Melanoma
    Oberle, Marion
    Jamme, Philippe
    Mansard, Sandrine
    Machet, Laurent
    Hervieu, Alice
    Kramkimel, Nora
    Greliak, Anna
    Jarrousse, Anne Sophie
    Derangere, Valentin
    Dudoignon, David
    Descarpentries, Clotilde
    Mortier, Laurent
    JCO PRECISION ONCOLOGY, 2022, 6
  • [45] Growth factor-mediated resistance to BRAF/MEK inhibitors in BRAF mutant melanoma
    Lutterbach, Bart
    Ware, Chris
    Davis, Lenora
    Zhang, Qing
    Zawel, Leigh
    Reilly, John
    Pan, Bo-Sheng
    CANCER RESEARCH, 2012, 72
  • [46] Efficacy and Adverse Events in Metastatic Melanoma Patients Treated with Combination BRAF Plus MEK Inhibitors Versus BRAF Inhibitors: A Systematic Review
    Greco, Austin
    Safi, Danish
    Swami, Umang
    Ginader, Tim
    Milhem, Mohammed
    Zakharia, Yousef
    CANCERS, 2019, 11 (12)
  • [47] Tattoo hypersensitivity reaction in a patient receiving combined BRAF and MEK inhibitors
    Rohmer, E.
    Scrivener, J-N
    Schissler, C.
    Cribier, B.
    Lenormand, C.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2019, 146 (11): : 725 - 729
  • [48] Patterns of progression in metastatic melanoma patients treated with Braf and Mek inhibitors: an Italian Melanoma Intergroup (IMI) study
    Marconcini, R.
    Marra, E.
    De Rosa, F.
    Stucci, L. S.
    Orgiano, L.
    Ribero, S.
    Bloise, F.
    Antonuzzo, A.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [49] Metastatic melanoma patients treated with Braf and Mek inhibitors: Patterns of progression. An Italian Melanoma Intergroup study
    Marconcini, R.
    Marra, E.
    De Rosa, F.
    Stucci, S. L.
    Orgiano, L.
    Ribero, S.
    Bloise, F.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2017, 28 : 63 - 64
  • [50] BRAF/MEK inhibitor rechallenge in advanced melanoma patients
    Van Not, Olivier J.
    van den Eertwegh, Alfons J. M.
    Haanen, John B.
    van Rijn, Rozemarijn S.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette W. P. J.
    Blank, Christian U.
    Boers-Sonderen, Marye J.
    de Groot, Jan Willem W. B.
    Hospers, Geke A. P.
    Kapiteijn, Ellen
    Bloem, Manja
    Piersma, Djura
    Stevense-den Boer, Marion
    Verheijden, Rik J.
    van der Veldt, Astrid A. M.
    Wouters, Michel W. J. M.
    Blokx, Willeke A. M.
    Suijkerbuijk, Karijn P. M.
    CANCER, 2024, 130 (09) : 1673 - 1683